SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-072252
Filing Date
2011-08-03
Accepted
2011-08-03 16:33:52
Documents
3
Period of Report
2011-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f59716e8vk.htm 8-K 10895
2 EX-99.1 f59716exv99w1.htm EX-99.1 87693
3 GRAPHIC f59716f5971601.gif GRAPHIC 7187
  Complete submission text file 0000950123-11-072252.txt   109768
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28298 | Film No.: 111007346
SIC: 2836 Biological Products, (No Diagnostic Substances)